vs
Side-by-side financial comparison of InvenTrust Properties Corp. (IVT) and RHYTHM PHARMACEUTICALS, INC. (RYTM). Click either name above to swap in a different company.
InvenTrust Properties Corp. is the larger business by last-quarter revenue ($77.4M vs $57.3M, roughly 1.4× RHYTHM PHARMACEUTICALS, INC.). InvenTrust Properties Corp. runs the higher net margin — 3.4% vs -83.0%, a 86.4% gap on every dollar of revenue. On growth, RHYTHM PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (36.9% vs 8.6%). Over the past eight quarters, RHYTHM PHARMACEUTICALS, INC.'s revenue compounded faster (48.5% CAGR vs 7.6%).
InvenTrust Properties Corp. is a real estate investment trust that invests in shopping malls. As of December 31, 2024, the company owned interests in 68 properties comprising 11.0 million square feet.
Rhythm Pharmaceuticals is a biopharmaceutical firm focused on developing and commercializing targeted therapies for rare genetic disorders causing severe unmanageable obesity, including POMC deficiency, LEPR deficiency, and Bardet-Biedl syndrome. It serves patients in North America and Europe who lack effective standard treatments for their chronic life-altering conditions.
IVT vs RYTM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $77.4M | $57.3M |
| Net Profit | $2.7M | $-47.5M |
| Gross Margin | — | 91.6% |
| Operating Margin | -11.0% | -82.2% |
| Net Margin | 3.4% | -83.0% |
| Revenue YoY | 8.6% | 36.9% |
| Net Profit YoY | -72.8% | -9.6% |
| EPS (diluted) | $0.02 | $-0.73 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $77.4M | $57.3M | ||
| Q3 25 | $74.5M | $51.3M | ||
| Q2 25 | $73.6M | $48.5M | ||
| Q1 25 | $73.8M | $32.7M | ||
| Q4 24 | $71.2M | $41.8M | ||
| Q3 24 | $68.5M | $33.3M | ||
| Q2 24 | $67.4M | $29.1M | ||
| Q1 24 | $66.8M | $26.0M |
| Q4 25 | $2.7M | $-47.5M | ||
| Q3 25 | $6.0M | $-52.9M | ||
| Q2 25 | $95.9M | $-46.6M | ||
| Q1 25 | $6.8M | $-49.5M | ||
| Q4 24 | $9.8M | $-43.3M | ||
| Q3 24 | $-539.0K | $-43.6M | ||
| Q2 24 | $1.5M | $-32.3M | ||
| Q1 24 | $2.9M | $-141.4M |
| Q4 25 | — | 91.6% | ||
| Q3 25 | — | 89.3% | ||
| Q2 25 | — | 88.6% | ||
| Q1 25 | — | 88.8% | ||
| Q4 24 | — | 90.9% | ||
| Q3 24 | — | 88.5% | ||
| Q2 24 | — | 89.9% | ||
| Q1 24 | — | 89.2% |
| Q4 25 | -11.0% | -82.2% | ||
| Q3 25 | -9.8% | -102.6% | ||
| Q2 25 | — | -93.4% | ||
| Q1 25 | -10.5% | -143.7% | ||
| Q4 24 | -3.6% | -98.6% | ||
| Q3 24 | -18.7% | -132.0% | ||
| Q2 24 | -13.6% | -139.2% | ||
| Q1 24 | -13.1% | -538.7% |
| Q4 25 | 3.4% | -83.0% | ||
| Q3 25 | 8.1% | -103.1% | ||
| Q2 25 | 130.4% | -96.1% | ||
| Q1 25 | 9.2% | -151.4% | ||
| Q4 24 | 13.8% | -103.6% | ||
| Q3 24 | -0.8% | -131.2% | ||
| Q2 24 | 2.2% | -110.9% | ||
| Q1 24 | 4.3% | -544.4% |
| Q4 25 | $0.02 | $-0.73 | ||
| Q3 25 | $0.08 | $-0.82 | ||
| Q2 25 | $1.23 | $-0.75 | ||
| Q1 25 | $0.09 | $-0.81 | ||
| Q4 24 | $0.14 | $-0.71 | ||
| Q3 24 | $-0.01 | $-0.73 | ||
| Q2 24 | $0.02 | $-0.55 | ||
| Q1 24 | $0.04 | $-2.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $388.9M |
| Total DebtLower is stronger | $825.9M | — |
| Stockholders' EquityBook value | $1.8B | $139.1M |
| Total Assets | $2.8B | $480.2M |
| Debt / EquityLower = less leverage | 0.46× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $388.9M | ||
| Q3 25 | — | $416.1M | ||
| Q2 25 | — | $291.0M | ||
| Q1 25 | — | $314.5M | ||
| Q4 24 | — | $320.6M | ||
| Q3 24 | — | $298.4M | ||
| Q2 24 | — | $319.1M | ||
| Q1 24 | — | $201.2M |
| Q4 25 | $825.9M | — | ||
| Q3 25 | $764.6M | — | ||
| Q2 25 | $746.3M | — | ||
| Q1 25 | $740.7M | — | ||
| Q4 24 | $740.4M | — | ||
| Q3 24 | $740.1M | — | ||
| Q2 24 | $812.2M | — | ||
| Q1 24 | $827.5M | — |
| Q4 25 | $1.8B | $139.1M | ||
| Q3 25 | $1.8B | $148.8M | ||
| Q2 25 | $1.8B | $-11.9M | ||
| Q1 25 | $1.7B | $18.9M | ||
| Q4 24 | $1.8B | $21.7M | ||
| Q3 24 | $1.8B | $11.2M | ||
| Q2 24 | $1.5B | $39.3M | ||
| Q1 24 | $1.5B | $61.6M |
| Q4 25 | $2.8B | $480.2M | ||
| Q3 25 | $2.7B | $506.9M | ||
| Q2 25 | $2.7B | $372.7M | ||
| Q1 25 | $2.6B | $386.7M | ||
| Q4 24 | $2.6B | $392.3M | ||
| Q3 24 | $2.6B | $363.6M | ||
| Q2 24 | $2.5B | $381.8M | ||
| Q1 24 | $2.5B | $258.7M |
| Q4 25 | 0.46× | — | ||
| Q3 25 | 0.42× | — | ||
| Q2 25 | 0.41× | — | ||
| Q1 25 | 0.42× | — | ||
| Q4 24 | 0.42× | — | ||
| Q3 24 | 0.42× | — | ||
| Q2 24 | 0.53× | — | ||
| Q1 24 | 0.53× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $155.4M | $-25.4M |
| Free Cash FlowOCF − Capex | $110.9M | — |
| FCF MarginFCF / Revenue | 143.3% | — |
| Capex IntensityCapex / Revenue | 57.5% | — |
| Cash ConversionOCF / Net Profit | 58.41× | — |
| TTM Free Cash FlowTrailing 4 quarters | $193.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $155.4M | $-25.4M | ||
| Q3 25 | $43.8M | $-26.6M | ||
| Q2 25 | $48.7M | $-23.3M | ||
| Q1 25 | $20.2M | $-40.4M | ||
| Q4 24 | $136.9M | $-18.8M | ||
| Q3 24 | $38.4M | $-25.2M | ||
| Q2 24 | $46.7M | $-29.1M | ||
| Q1 24 | $14.8M | $-40.7M |
| Q4 25 | $110.9M | — | ||
| Q3 25 | $31.4M | — | ||
| Q2 25 | $38.0M | — | ||
| Q1 25 | $12.8M | — | ||
| Q4 24 | $100.8M | — | ||
| Q3 24 | $29.3M | — | ||
| Q2 24 | $37.2M | — | ||
| Q1 24 | $7.7M | — |
| Q4 25 | 143.3% | — | ||
| Q3 25 | 42.2% | — | ||
| Q2 25 | 51.6% | — | ||
| Q1 25 | 17.4% | — | ||
| Q4 24 | 141.5% | — | ||
| Q3 24 | 42.8% | — | ||
| Q2 24 | 55.2% | — | ||
| Q1 24 | 11.5% | — |
| Q4 25 | 57.5% | — | ||
| Q3 25 | 16.7% | — | ||
| Q2 25 | 14.6% | — | ||
| Q1 25 | 10.0% | — | ||
| Q4 24 | 50.7% | — | ||
| Q3 24 | 13.3% | — | ||
| Q2 24 | 14.0% | — | ||
| Q1 24 | 10.6% | — |
| Q4 25 | 58.41× | — | ||
| Q3 25 | 7.27× | — | ||
| Q2 25 | 0.51× | — | ||
| Q1 25 | 2.97× | — | ||
| Q4 24 | 13.97× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 31.15× | — | ||
| Q1 24 | 5.10× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
